Ohcanbohtosat - Lutz Jermutus

Aiddostahte ozu
  1. 1
    Tailoring<i>in vitro</i>evolution for protein affinity or stability

    Tailoring<i>in vitro</i>evolution for protein affinity or stability Dahkki Lutz Jermutus, Annemarie Honegger, Falk Schwesinger, Jozef Hanes, Andreas Plückthun

    Almmustuhtton 2000
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Identification of cyclic peptides able to mimic the functional epitope of IgG1‐Fc for human FcyRI

    Identification of cyclic peptides able to mimic the functional epitope of IgG1‐Fc for human FcyRI Dahkki Stéphane Bonetto, Loredana Spadola, Andrew Buchanan, Lutz Jermutus, John Lund

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Exploiting protease activation for therapy

    Exploiting protease activation for therapy Dahkki Chloe Bleuez, Wolfgang F. Koch, Carole Urbach, Florian Hollfelder, Lutz Jermutus

    Almmustuhtton 2022
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Ribosome display efficiently selects and evolves high-affinity antibodies<i>in vitro</i>from immune libraries

    Ribosome display efficiently selects and evolves high-affinity antibodies<i>in vitro</i>from immune libraries Dahkki Jozef Hanes, Lutz Jermutus, Susanne Weber-Bornhauser, Hans Rudolf Bosshard, Andreas Plückthun

    Almmustuhtton 1998
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Challenges and opportunities for non-antibody scaffold drugs

    Challenges and opportunities for non-antibody scaffold drugs Dahkki Rodrigo Vazquez-Lombardi, Tri Giang Phan, Carsten Zimmermann, David C. Lowe, Lutz Jermutus, Daniel Christ

    Almmustuhtton 2015
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potency

    A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potency Dahkki Matthieu Chodorge, Sara Züger, Christian U. Stirnimann, Christophe Briand, Lutz Jermutus, Markus G. Grütter, Ralph Minter

    Almmustuhtton 2012
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study

    Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study Dahkki Rajaa Nahra, Tao Wang, Kishore M. Gadde, Jan Oscarsson, Michael Stümvoll, Lutz Jermutus, Boaz Hirshberg, Philip Ambery

    Almmustuhtton 2021
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    MEDI0382, a GLP‐1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single‐dose, healthy‐subject, randomized, Phase 1 study

    MEDI0382, a GLP‐1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single‐dose, healthy‐subject, randomized, Phase 1 study Dahkki Philip Ambery, Sebastian Klammt, Maximillian G. Posch, Marcella Petrone, Wenji Pu, Cristina M. Rondinone, Lutz Jermutus, Boaz Hirshberg

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Unbinding forces of single antibody-antigen complexes correlate with their thermal dissociation rates

    Unbinding forces of single antibody-antigen complexes correlate with their thermal dissociation rates Dahkki Falk Schwesinger, Robert Ros, Torsten Strunz, Dario Anselmetti, H.-J. Güntherodt, Annemarie Honegger, Lutz Jermutus, Louis Tiefenauer, Andreas Plückthun

    Almmustuhtton 2000
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Safety and Efficacy of Novel Incretin Co-agonist Cotadutide in Biopsy-proven Noncirrhotic MASH With Fibrosis

    Safety and Efficacy of Novel Incretin Co-agonist Cotadutide in Biopsy-proven Noncirrhotic MASH With Fibrosis Dahkki Sudha S. Shankar, Samuel J. Daniels, Darren Robertson, Janeli Sarv, José Sánchez, Debra Carter, Lutz Jermutus, Benjamin Challis, Arun J. Sanyal

    Almmustuhtton 2024
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Probing a protein–protein interaction by <i>in vitro</i> evolution

    Probing a protein–protein interaction by <i>in vitro</i> evolution Dahkki George Thom, Alexis C. Cockroft, Andrew Buchanan, Cathy Joberty Candotti, E. Suzanne Cohen, David Lowne, Phill Monk, Celia P. Shorrock-Hart, Lutz Jermutus, Ralph Minter

    Almmustuhtton 2006
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Engineering a therapeutic IgG molecule to address cysteinylation, aggregation and enhance thermal stability and expression

    Engineering a therapeutic IgG molecule to address cysteinylation, aggregation and enhance thermal stability and expression Dahkki Andrew Buchanan, Veronica Clementel, Rob Woods, Nicholas Harn, Michael A. Bowen, Wenjun Mo, Bojana Popovic, Steven M. Bishop, William F. Dall’Acqua, Ralph Minter, Lutz Jermutus, Vahe Bedian

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Structural and Pharmacological Characterization of Novel Potent and Selective Monoclonal Antibody Antagonists of Glucose-dependent Insulinotropic Polypeptide Receptor

    Structural and Pharmacological Characterization of Novel Potent and Selective Monoclonal Antibody Antagonists of Glucose-dependent Insulinotropic Polypeptide Receptor Dahkki Peter Ravn, Chaithanya Madhurantakam, Susan Kunze, Evelyn Matthews, Claire Priest, Siobhan O’Brien, Andie Collinson, Monika Papworth, Maria Fritsch-Fredin, Lutz Jermutus, Lambertus Benthem, M.G. Gruetter, Ronald H. Jackson

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Combining phenotypic and proteomic approaches to identify membrane targets in a ‘triple negative’ breast cancer cell type

    Combining phenotypic and proteomic approaches to identify membrane targets in a ‘triple negative’ breast cancer cell type Dahkki Steven Rust, Sandrine Guillard, Kris F. Sachsenmeier, Carl Hay, Max Davidson, Anders Karlsson, Roger Karlsson, Erin Brand, David Lowne, John Elvin, Matt Flynn, Gene Kurosawa, Robert E. Hollingsworth, Lutz Jermutus, Ralph Minter

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Dual <scp>glucagon‐like peptide</scp>‐1 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity

    Dual <scp>glucagon‐like peptide</scp>‐1 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity Dahkki Rajna Golubić, Jane Kennet, Victoria Parker, Darren Robertson, Dan Luo, Lars Hansen, Lutz Jermutus, Philip Ambery, Maria Ryaboshapkina, Manasa Surakala, Rhianna C. Laker, Michelle Venables, Albert Koulman, Adrian Park, Mark L. Evans

    Almmustuhtton 2024
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Identification of anti-tumour biologics using primary tumour models, 3-D phenotypic screening and image-based multi-parametric profiling

    Identification of anti-tumour biologics using primary tumour models, 3-D phenotypic screening and image-based multi-parametric profiling Dahkki Alan M. Sandercock, Steven Rust, Sandrine Guillard, Kris F. Sachsenmeier, Nick Holoweckyj, Carl Hay, Matt Flynn, Qihui Huang, Kuan Yan, Bram Herpers, Leo Price, Jo Soden, Jim Freeth, Lutz Jermutus, Robert E. Hollingsworth, Ralph Minter

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Efficacy and safety of cotadutide, a dual glucagon‐like peptide‐1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease

    Efficacy and safety of cotadutide, a dual glucagon‐like peptide‐1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney... Dahkki Victoria Parker, Thuong Hoang, Heike Schlichthaar, Fraser W. Gibb, Barbara Wenzel, Maximillian G. Posch, Ludger Rose, Yi‐Ting Chang, Marcella Petrone, Lars Hansen, Philip Ambery, Lutz Jermutus, Hiddo J.L. Heerspink, Rory J. McCrimmon

    Almmustuhtton 2022
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Sustained peripheral depletion of amyloid-β with a novel form of neprilysin does not affect central levels of amyloid-β

    Sustained peripheral depletion of amyloid-β with a novel form of neprilysin does not affect central levels of amyloid-β Dahkki Simon J. Henderson, Christin Andersson, Rajesh Narwal, Juliette Janson, Tom J. Goldschmidt, Paulina Appelkvist, Anna Bogstedt, Ann-Charlott Steffen, Ulrich Haupts, Jan Tebbe, Per Ola Freskgård, Lutz Jermutus, Matthew Burrell, Susan B. Fowler, Carl I. Webster

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor

    LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor Dahkki Xuecai Ge, Hong Yang, Maria A. Bednarek, Hadas Galon-Tilleman, Peirong Chen, Michael Chen, Joshua S. Lichtman, Yan Wang, Olivier Dalmas, Yiyuan Yin, Hui Tian, Lutz Jermutus, Joseph Grimsby, Cristina M. Rondinone, Anish Konkar, Daniel D. Kaplan

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics

    The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics Dahkki Siva Charan Devanaboyina, Sandra Lynch, Raimund J. Ober, Sripad Ram, Dong Young Kim, Alberto Puig-Canto, Shannon Breen, Srinath Kasturirangan, Susan B. Fowler, Li Peng, Haihong Zhong, Lutz Jermutus, Herren Wu, Carl I. Webster, E. Sally Ward, Changshou Gao

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: